Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Injuries 4Medulloblastoma 3Choroid Plexus Neoplasms 3Central Nervous System Neoplasms 3Brain Neoplasms 3Astrocytoma 3Pinealoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Meningioma 2Gliosarcoma 2Glioma, Subependymal 2Glioma 2Glioblastoma 2Fatigue 2Ependymoma 2Depression 2Craniopharyngioma 2Cognitive Dysfunction 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Retention 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Pain 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Music Therapy 15Therapeutics 14Surveys and Questionnaires 13Cognitive Behavioral Therapy 13Psychiatric Rehabilitation 12Methods 9Standard of Care 8Educational Status 8Early Intervention, Educational 8Psilocybin 7Mindfulness 6Ketamine 6Hypnosis 6Control Groups 6Aromatherapy 6Acupuncture Therapy 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Counseling 5Art Therapy 5Saline Solution 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Caregivers 4Behavior Therapy 4Autogenic Training 4Yoga 3Weights and Measures 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Donepezil × Clear all
NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Wake Forest University Health Sciences

Phase 2 Completed
62 enrolled 12 charts
Breast

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡